Ballentine Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.69M | Buy |
|
|||||
|
2025
Q2 | $2.39M | Sell |
|
|||||
|
2025
Q1 | $2.55M | Buy |
|
|||||
|
2024
Q4 | $2M | Sell |
|
|||||
|
2024
Q3 | $2.52M | Buy |
|
|||||
|
2024
Q2 | $2.24M | Buy |
|
|||||
|
2024
Q1 | $1.6M | Buy |
|
|||||
|
2023
Q4 | $1.2M | Buy |
|
|||||
|
2023
Q3 | $1.05M | Sell |
|
|||||
|
2023
Q2 | $1.13M | Buy |
|
|||||
|
2023
Q1 | $835K | Sell |
|
|||||
|
2022
Q4 | $818K | Buy |
|
|||||
|
2022
Q3 | $487K | Sell |
|
|||||
|
2022
Q2 | $618K | Buy |
|
|||||
|
2022
Q1 | $499K | Buy |
|
|||||
|
2021
Q4 | $437K | Sell |
|
|||||
|
2021
Q3 | $470K | Buy |
|
|||||
|
2021
Q2 | $430K | Buy |
|
|||||
|
2021
Q1 | $356K | Buy |
|
|||||
|
2020
Q4 | $342K | Sell |
|
|||||
|
2020
Q3 | $402K | Buy |
|
|||||
|
2020
Q2 | $360K | Buy |
|
|||||
|
2020
Q1 | $293K | Buy |
|
|||||
|
2019
Q4 | $324K | Buy |
|
|||||
|
2019
Q3 | $254K | Buy |
|
|||||
|
2019
Q2 | $228K | Buy |
|